Pfizer Inc (PFE) returns
Pfizer returns over 10 years
$1,000 invested in Pfizer ten years ago was worth $1,589 at the close on October 30, 2026, with dividends reinvested: an average return of 4.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +7.0% | — | $1,070 | -0.9% |
| 3 months | +22.5% | — | $1,225 | +2.1% |
| Year to date | +28.9% | — | $1,289 | +11.7% |
| 1 year | +34.5% | — | $1,345 | +12.4% |
| 3 years | +21.2% | +6.6% | $1,212 | +88.5% |
| 5 years | -9.0% | -1.9% | $909.96 | +76.0% |
| 10 years | +58.9% | +4.7% | $1,589 | +316.6% |
Pfizer return by calendar year
| Year | PFE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +28.9% | +11.7% | +17.2% |
| 2025 | +0.7% | +17.7% | -17.0% |
| 2024 | -2.2% | +24.9% | -27.1% |
| 2023 | -41.2% | +26.2% | -67.4% |
| 2022 | -10.4% | -18.2% | +7.7% |
| 2021 | +66.7% | +28.7% | +38.0% |
| 2020 | +3.1% | +18.4% | -15.2% |
| 2019 | -6.9% | +31.2% | -38.1% |
| 2018 | +24.8% | -4.6% | +29.4% |
| 2017 | +15.9% | +21.7% | -5.8% |
| 2016 | +4.5% | +12.0% | -7.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PFE financials · PFE valuation
No forecast, no recommendation. This page describes Pfizer Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.